Abstract

Nature leads this week with a story about the Bush administration's surprisingly liberal overtures to Third World countries that want to develop inexpensive AIDS medications. Efforts to unify the European research effort are the focus of Science's lead article.

Highlights

  • Nature leads this week with a story about the Bush administration’s surprisingly liberal overtures to Third World countries that want to develop inexpensive AIDS medications

  • Nature reports that Father Angelo d’Agostino, head of Nyumbani Orphanage for children with HIV or AIDS in the Kenyan capital Nairobi, plans to start buying anti-AIDS drugs from the Indian company Cipla of Mumbai, which has promised to make the drugs available at about one-third of the minimum cost on offer from the Western companies

  • Big Pharma is not happy about the cheap drugs - 42 pharmaceutical companies are currently challenging a South African decision to allow domestic production of generic AIDS drugs - the previous US administration had adopted a “relaxed attitude” toward countries wishing to produce their own versions of expensive Western AIDS drugs, says Nature

Read more

Summary

Introduction

Nature leads this week with a story about the Bush administration’s surprisingly liberal overtures to Third World countries that want to develop inexpensive AIDS medications. Efforts to unify the European research effort are the focus of Science’s lead article. AIDS has ravaged many African and South American countries in the past several years.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.